✦ LIBER ✦

The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma

✍ Scribed by Edward F. McClay; Michael J. Mastrangelo; John D. Sprandio; Robert E. Bellet; David Berd

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 383 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890401)63:7<1292::aid-cncr2820630711>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cisplatin with dacarbazine and

High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma

✍ Giorgio Cocconi; Antonio C. Buzaid 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

High-dose cisplatin with dacarbazine and

High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma

✍ Antonio C. Buzaid; John R. Murren; Henry J. Durivage 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

High-dose cisplatin plus dacarbazine in

High-dose cisplatin plus dacarbazine in the treatment of metastatic melanoma

✍ John R. Murren; William Derosa; Henry J. Durivage; Carol Davis; Robert Makuch; C 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 420 KB 👁 2 views

Vinorelbine and cisplatin (CIVIC regimen

Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens

✍ Isabelle Ray-Coquard; Pierre Biron; Thomas Bachelot; Jean-Paul Guastalla; Gilles 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Background: A pilot study of a new chemotherapy, the civic regimen, was performed in 58 patients with metastatic breast carcinoma previously treated with chemotherapy with or without hormonal therapy (n = 41). cisplatin, 20 mg/m2/day, was given (days 1-5) every 21 days during a 1-hour intravenou

A phase III randomized trial of dacarbaz

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma

✍ Sanjiv S. Agarwala; William Ferri; William Gooding; John M. Kirkwood 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 3 views

## BACKGROUND. Metastatic melanoma is a disease associated with a poor prognosis, and dacarbazine is still the reference agent. The authors conducted a randomized trial to test the benefit of adding tamoxifen to dacarbazine and carboplatin chemotherapy for previously untreated patients with metast

A clinical trial of intravenous vinorelb

A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treatment of patients with advanced malignant melanoma

✍ Lynn G. Feun; Niramol Savaraj; Judith Hurley; Angela Marini; Shenghan Lai 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

## BACKGROUND. The aim of the current trial was to assess the efficacy and toxicity of weekly intravenous vinorelbine tartrate with daily oral tamoxifen in the treatment of patients with advanced or metastatic malignant melanoma. ## METHODS. Thirty-one patients were treated with vinorelbine tartr